| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |